ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag emotions genetics genomics

Toward a “Clickable Plant”
Jane Salodof Macneil | Feb 15, 2004 | 9 min read
By conscious design, plant genomics initiatives have devoted initial resources to new technology development. Part of that money went to developing functional genomics approaches, and part to new sequencing technologies.
Privatizing the Human Genome?
Paul Smaglik | Jun 7, 1998 | 10 min read
Principals behind joint-venture proposal and public effort seek to define relationships A private effort to sequence the human genome four years ahead of the Human Genome Project's 2005 goal could either compete directly with the federal project or meld seamlessly with it. Before any relationship between the two efforts becomes formalized, scientists and federal officials involved with the Human Genome Project must determine whether the private approach will work, who will own the data, how qu
Science Museums Exhibit Renewed Vigor
Christine Bahls | Mar 28, 2004 | 10+ min read
Erica P. JohnsonApreschool girl with black braids presses a finger to a disk that twists a brightly lit DNA model, transforming its ladder shape into a double helix. Her head bops from side to side in wonder as the towering DNA coils and straightens. When a bigger boy claims her place, the girl joins meandering moms and dads with their charges as they twist knobs, open flaps, and simply stare at flashing helixes and orange information boards: all a part of the museum exhibit called "Genome: The
Mail
The Scientist Staff | Dec 1, 2007 | 6 min read
To frame, or not to frame? Re: "The future of public engagement,"1 the first thing scientists need to do is abandon all talk of tentativeness, paradigms, and social construct when talking to the public about science. This model of science is appropriate in certain circles, but I see not a shred of evidence that it has improved public scientific literacy, and [I see] a great deal of evidence that it has been used by charlatans to dismiss scientific findings or push bogus alternativ
Immune to Failure
Karen Hopkin | Feb 1, 2013 | 9 min read
With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.
Notebook
Eugene Russo | Dec 5, 1999 | 7 min read
Contents Pivotal pump Leptin limbo Clue to obesity Biotech Web site Helping hand Mapping malaria Notebook Pictured above are pigmented bacterial colonies of Deinococcus radiodurans, the most radiation-resistant organism currently known. DEINO-MITE CLEANUP In 1956, investigators discovered a potentially invaluable cleanup tool in an unlikely place. A hardy bacterium called Deinococcus radiodurans unexpectedly thrived in samples of canned meat thought to be sterilized by gamma radiation. The b
Misguided Expectations?
Franklin Hoke | Dec 11, 1994 | 8 min read
Manufacturer Up In Arms Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, angeri
Limited Access To cDNA Database Has Drug Manufacturer Up In Arms
Franklin Hoke | Dec 11, 1994 | 8 min read
Date : December 12, 1994 Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, an
Misguided Expectations?
Franklin Hoke | Dec 11, 1994 | 8 min read
Manufacturer Up In Arms Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, angeri
Limited Access To cDNA Database Has Drug Manufacturer Up In Arms
Franklin Hoke | Dec 11, 1994 | 8 min read
Date : December 12, 1994 Incensed that the terms exclude industrial scientists, Merck announces sponsorship of competing project A powerful new, privately held database of human complementary DNA (cDNA) sequences has become available to researchers eager to test its capabilities to rapidly identify new genes. The proposed terms of access to the database, however, exclude pharmaceutical and other industry-affiliated scientists, an

Run a Search

ADVERTISEMENT